Intensity Therapeutics, Inc. (INTS) Misses Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts INTS Hot Sheet
Join SI Premium – FREE
Intensity Therapeutics, Inc. (NASDAQ: INTS) reported Q2 EPS of ($0.36), $0.04 worse than the analyst estimate of ($0.32).
For earnings history and earnings-related data on Intensity Therapeutics, Inc. (INTS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UGI shares spike on reported KKR bid for the company
- UGI Corp. (UGI) halted on volatility, up 6%
- Sypris Solutions (SYPR) Reports Q2 Loss of $0.14
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
